Company Filing History:
Years Active: 2025
Title: Ross Mclellan: Innovator in Pharmaceutical Chemistry
Introduction
Ross Mclellan is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on crystalline forms of aminoguandinium salts. His research has implications for enhancing solubility in medicinal applications.
Latest Patents
Mclellan holds a patent for "Polymorphs of phenyl pyrrole aminoguandium salts." This patent describes crystalline forms of N-{3-[1-(2-nitrophenyl)-1H-pyrrol-2-yl]-allylidene}-aminoguanidinium salts that exhibit high solubility. The disclosure emphasizes the potential use of these crystalline forms in medicine, showcasing Mclellan's commitment to advancing healthcare solutions.
Career Highlights
Ross Mclellan is currently associated with Synact Pharma Aps, where he continues to push the boundaries of pharmaceutical research. His work is characterized by a focus on developing innovative compounds that can lead to improved therapeutic outcomes.
Collaborations
Mclellan collaborates with esteemed colleagues such as Thomas Boesen and Thomas Engelbrecht Nordkild Jonassen. These partnerships enhance the research environment and foster the exchange of ideas, contributing to the advancement of their collective work.
Conclusion
In summary, Ross Mclellan is a distinguished inventor whose work in pharmaceutical chemistry is paving the way for new medicinal applications. His innovative approach and collaborative spirit are vital to the ongoing evolution of the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.